Unicycive Therapeutics, Inc.
UNCY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001766140
No open-market purchases or sales by Unicycive Therapeutics, Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $54.6M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Unicycive Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −9 vs. Q1 2025
- Shares held
- 5.14M
- −848.5K (−14.2%) vs. Q1 2025Converted for a 1-for-10 split
- Total value
- $24.6M
- −$9.83M (−28.5%) vs. Q1 2025
- New holders
- 5
- 5 more added
- Sold out
- 14
- 4 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting UNCY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 79 | $54.6M |
| Q1 2026 | 51 | $65.2M |
| Q4 2025 | 35 | $47.5M |
| Q3 2025 | 30 | $27.4M |
| Q2 2025 | 20 | $24.6M |
| Q1 2025 | 29 | $34.5M |
| Q4 2024 | 31 | $49.0M |
| Q3 2024 | 29 | $19.1M |
| Q2 2024 | 24 | $9.52M |
| Q1 2024 | 23 | $31.6M |
| Q4 2023 | 16 | $11.3M |
| Q3 2023 | 16 | $12.2M |
| Q2 2023 | 15 | $1.38M |
| Q1 2023 | 13 | $3.54M |
| Q4 2022 | 9 | $428.3K |
| Q3 2022 | 12 | $571.0K |
| Q2 2022 | 15 | $992.0K |
| Q1 2022 | 12 | $1.48M |
| Q4 2021 | 12 | $2.30M |
| Q3 2021 | 10 | $3.02M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Unicycive Therapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vivo Capital, LLC | 1,137,015 | $5.42M | 0.56% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Octagon Capital Advisors LP | 1,000,000 | $4.77M | 1.05% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Nantahala Capital Management, LLC | 939,202 | $4.56M | 0.32% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Great Point Partners LLC | 796,558 | $3.80M | 2.47% | −301,442−27.5% | ReducedConverted for a 1-for-10 split |
| Vanguard Group Inc | 605,953 | $2.89M | 0.00% | +484,709+399.8% | AddedConverted for a 1-for-10 split |
| Logos Global Management LP | 473,562 | $2.26M | 0.30% | −34,331−6.8% | ReducedConverted for a 1-for-10 split |
| Acuta Capital Partners, LLC | 62,899 | $300.0K | 0.42% | −172,390−73.3% | ReducedConverted for a 1-for-10 split |
| Geode Capital Management, LLC | 58,786 | $280.4K | 0.00% | +866+1.5% | AddedConverted for a 1-for-10 split |
| JPMorgan Chase & Co | 21,709 | $103.6K | 0.00% | +21,691+117,883.7% | AddedConverted for a 1-for-10 split |
| State Street Corp | 12,523 | $59.7K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Renaissance Technologies LLC | 11,790 | $56.2K | 0.00% | +11,790 | New |
| Lazard Asset Management LLC | 11,575 | $55.0K | 0.00% | +11,575 | New |
| Northern Trust Corp | 10,787 | $51.5K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Morgan Stanley | 1,000 | $4.77K | 0.00% | −1,227−55.1% | ReducedConverted for a 1-for-10 split |
| SBI Securities Co., Ltd. | 553 | $2.64K | 0.00% | +551+22,020.0% | AddedConverted for a 1-for-10 split |
| Harbour Investments, Inc. | 100 | $477 | 0.00% | +100 | New |
| Barclays PLC | 80 | $382 | 0.00% | +80 | New |
| Bank of America Corp | 64 | $305 | 0.00% | +21+49.5% | AddedConverted for a 1-for-10 split |
| Bogart Wealth, LLC | 6 | $29 | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Danske Bank A/S | 1 | $5 | 0.00% | +1 | New |
| Walleye Capital LLC | 0 | $0 | 0.00% | −409,426−100.0% | Sold outConverted for a 1-for-10 split |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −241,349−100.0% | Sold outConverted for a 1-for-10 split |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −175,000−100.0% | Sold outConverted for a 1-for-10 split |
| XTX Topco Ltd | 0 | $0 | 0.00% | −12,323−100.0% | Sold outConverted for a 1-for-10 split |
| BlackRock, Inc. | 0 | $0 | 0.00% | −8,324−100.0% | Sold outConverted for a 1-for-10 split |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −7,348−100.0% | Sold outConverted for a 1-for-10 split |
| Virtu Financial LLC | 0 | $0 | 0.00% | −3,887−100.0% | Sold outConverted for a 1-for-10 split |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −3,297−100.0% | Sold outConverted for a 1-for-10 split |
| Creative Planning | 0 | $0 | 0.00% | −2,591−100.0% | Sold outConverted for a 1-for-10 split |
| HRT Financial LP | 0 | $0 | 0.00% | −1,782−100.0% | Sold outConverted for a 1-for-10 split |
| Tandem Capital Management Corp | 0 | $0 | 0.00% | −1,550−100.0% | Sold outConverted for a 1-for-10 split |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −1,484−100.0% | Sold outConverted for a 1-for-10 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −1,204−100.0% | Sold outConverted for a 1-for-10 split |
| UBS Group AG | 0 | $0 | 0.00% | −955−100.0% | Sold outConverted for a 1-for-10 split |